Pages that link to "Q33657671"
Jump to navigation
Jump to search
The following pages link to BR96 sFv-PE40 immunotoxin: nonclinical safety assessment (Q33657671):
Displaying 8 items.
- A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications (Q34386184) (← links)
- Designing immunotoxins for cancer therapy. (Q34630307) (← links)
- Ability of luteinizing hormone releasing hormone-Pseudomonas aeruginosa exotoxin 40 binding to LHRH receptor on human liver cancer cells (Q36065616) (← links)
- Intraperitoneal administration of gonadotropin-releasing hormone-PE40 induces castration in male rats (Q37240438) (← links)
- Immunotoxin therapy of cancer (Q56454451) (← links)
- Immunotoxins for targeted cancer therapy (Q79199423) (← links)
- Immunological hormone atrophy by gonadotropin-based drug (Q79556040) (← links)
- Targeting of CD22-positive B-cell lymphoma cells by synthetic divalent sialic acid analogues (Q84553201) (← links)